Search results
Dec 1, 2020 · Although treatment of myotonic dystrophy type 1 and myotonic dystrophy type 2 is currently limited to supportive therapies, new therapeutic approaches based on pathogenic mechanisms may become feasible in near future.
Mar 15, 2024 · Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are autosomal dominant, multisystem disorders characterized by skeletal muscle weakness and myotonia, cardiac conduction abnormalities, iridescent cataracts, and other abnormalities. The management and prognosis of patients with DM will be reviewed here.
Jun 26, 2023 · There are two major forms recognized based on clinical and molecular presentation: Myotonic dystrophy type I (DM1), known as Steinert disease, and myotonic dystrophy type II (DM2), or proximal myotonic myopathy which is a milder variety of DMI. These are progressive, multisystem genetic disorders.
Mar 19, 2024 · Although there is no cure for myotonic dystrophy, a person may receive treatment for complications such as cataracts and diabetes. Read on to learn more about myotonic dystrophy and its...
Dec 12, 2022 · There are two main forms of myotonic dystrophy: Myotonic dystrophy type 1 (DM1), also known as Steinert disease. DM1 has four types: classic, mild, congenital and childhood. Myotonic dystrophy type 2 (DM2), also known as proximal myotonic myopathy. Their symptoms overlap, but DM2 tends to be milder than DM1.
Sep 27, 2021 · The aim of this article is to provide an overview on the current and upcoming therapeutic options for patients with myotonic dystrophy type 2 (DM2). At the moment, no disease-modifying therapies are available for DM2; next-generation therapies may however be available in the near future.
Dec 10, 2018 · Myotonic dystrophy type 2 (DM2) is a rare, progressive multisystem disease particularly affecting the skeletal muscle. A causal therapy is not yet available; however, prompt, appropriate symptomatic treatments are essential to limit disease-related complications.
